Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_assertion type Assertion NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_head.
- NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_provenance.
- NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_assertion evidence source_evidence_literature NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_provenance.
- NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_assertion SIO_000772 12240753 NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_provenance.
- NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_assertion wasDerivedFrom befree-2016 NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_provenance.
- NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_assertion wasGeneratedBy ECO_0000203 NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_provenance.